Keybank National Association OH Buys 14,598 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Keybank National Association OH increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 1.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 954,906 shares of the company's stock after acquiring an additional 14,598 shares during the period. Keybank National Association OH owned about 0.21% of GE HealthCare Technologies worth $74,655,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the stock. LGT Financial Advisors LLC grew its stake in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock valued at $25,000 after purchasing an additional 251 shares in the last quarter. Ashton Thomas Securities LLC acquired a new stake in shares of GE HealthCare Technologies in the third quarter worth $26,000. Capital Performance Advisors LLP acquired a new position in GE HealthCare Technologies during the 3rd quarter worth $26,000. Darwin Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at about $31,000. Finally, Continuum Advisory LLC grew its holdings in GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after buying an additional 168 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 1.4 %

Shares of GEHC traded up $1.17 on Friday, reaching $86.58. 4,075,712 shares of the company's stock were exchanged, compared to its average volume of 2,984,066. The business has a 50 day moving average price of $86.63 and a two-hundred day moving average price of $86.13. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $39.59 billion, a P/E ratio of 20.00, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80.

Remove Ads

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of research analyst reports. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. Finally, Citigroup lifted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.